These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12597457)

  • 1. Relevance of hepatic preneoplasia for human hepatocarcinogenesis.
    Su Q; Bannasch P
    Toxicol Pathol; 2003; 31(1):126-33. PubMed ID: 12597457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia.
    Su Q; Benner A; Hofmann WJ; Otto G; Pichlmayr R; Bannasch P
    Virchows Arch; 1997 Dec; 431(6):391-406. PubMed ID: 9428927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instability.
    Zerban H; Radig S; Kopp-Schneider A; Bannasch P
    Carcinogenesis; 1994 Nov; 15(11):2467-73. PubMed ID: 7955093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of hepatic preneoplasia in risk identification and early detection of neoplasia.
    Bannasch P; Haertel T; Su Q
    Toxicol Pathol; 2003; 31(1):134-9. PubMed ID: 12597458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonality of nodular lesions in liver cirrhosis and chromosomal abnormalities in monoclonal nodules of altered hepatocytes.
    Gong L; Li YH; Su Q; Chu X; Zhang W
    Histopathology; 2010 Apr; 56(5):589-99. PubMed ID: 20459569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal hepatic glycogenosis.
    Bannasch P; Jahn U; Hacker H; Su Q; Hoffmann W; Pichlmayr R; Otto G
    Int J Oncol; 1997 Feb; 10(2):261-8. PubMed ID: 21533371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of hepatic preneoplasia for cancer chemoprevention.
    Bannasch P; Nehrbass D; Kopp-Schneider A
    IARC Sci Publ; 2001; 154():223-40. PubMed ID: 11220662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis.
    Plentz RR; Park YN; Lechel A; Kim H; Nellessen F; Langkopf BH; Wilkens L; Destro A; Fiamengo B; Manns MP; Roncalli M; Rudolph KL
    Hepatology; 2007 Apr; 45(4):968-76. PubMed ID: 17393506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of the preneoplastic lesions of small hepatocellular carcinoma in cirrhotic livers.
    Seki S; Sakaguchi H; Kawakita N; Yanai A; Tamori A; Yabusako T; Nishiguchi S; Kuroki T; Kobayashi K; Monna T
    J Gastroenterol Hepatol; 1993; 8(6):582-9. PubMed ID: 7904190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First approaches for the transplantation of hepatocytes from Wistar rat preneoplastic livers into healthy recipients.
    Vera MC; Biancardi ME; Bottai H; Lugano MC; Quiroga AD; Pisani GB; Quintana AB
    Rev Esp Enferm Dig; 2019 May; 111(5):351-357. PubMed ID: 30767553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis.
    Lee RG; Tsamandas AC; Demetris AJ
    Hepatology; 1997 Dec; 26(6):1415-22. PubMed ID: 9397980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preneoplastic lesions in chronic hepatitis C.
    Thung SN; Hytiroglou P; Fiel I; Theise N
    Princess Takamatsu Symp; 1995; 25():171-8. PubMed ID: 8875622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell proliferative activity in adenomatous hyperplasia of the liver and small hepatocellular carcinoma. An immunohistochemical study demonstrating proliferating cell nuclear antigen.
    Terada T; Nakanuma Y
    Cancer; 1992 Aug; 70(3):591-8. PubMed ID: 1352480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced in stop experiments by oral exposure to N-nitrosomorpholine.
    Weber E; Bannasch P
    Carcinogenesis; 1994 Jun; 15(6):1227-34. PubMed ID: 8020160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by single oral exposures to N-nitrosomorpholine.
    Weber E; Bannasch P
    Carcinogenesis; 1994 Jun; 15(6):1219-26. PubMed ID: 8020159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular and metabolic changes in human clear cell liver foci].
    Ribback S; Calvisi DF; Cigliano A; Rausch J; Heidecke CD; Birth M; Dombrowski F
    Pathologe; 2015 Nov; 36 Suppl 2():210-5. PubMed ID: 26483250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preneoplastic lesions in human hepatocarcinogenesis.
    Libbrecht L; Desmet V; Roskams T
    Liver Int; 2005 Feb; 25(1):16-27. PubMed ID: 15698394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of glucose-6-phosphate-dehydrogenase in rat hepatic preneoplasia and neoplasia.
    Stumpf H; Bannasch P
    Int J Oncol; 1994 Dec; 5(6):1255-60. PubMed ID: 21559706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in the expression of glucose transporter protein GLUT 2 in preneoplastic and neoplastic hepatic lesions and reexpression of GLUT 1 in late stages of hepatocarcinogenesis.
    Grobholz R; Hacker HJ; Thorens B; Bannasch P
    Cancer Res; 1993 Sep; 53(18):4204-11. PubMed ID: 8364915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.